Adipose differentiation-related protein (ADRP) is associated with intracellular lipid droplets that accumulate neutral lipids. Here we report that ADRP expression in a human choriocarcinoma cell line, BeWo, is regulated through activation of retinoid X receptor (RXR) and peroxisome proliferator-activated receptor-g g (PPARg g). 
Intracellular lipid droplet (LD) is a cellular organelle observed ubiquitously in many cell types including chorionic cells. LDs are storage sites for neutral lipids and may play a central role in whole body energy homeostasis and distribution of lipids. 1, 2) Adipose differentiation-related protein (ADRP; also called as ADFP or adipophilin) is a major LDforming protein expressed in a wide variety of cells and tissues including placenta. [3] [4] [5] [6] [7] Addition of high concentrations of fatty acids to various cells in culture up-regulates both Adrp mRNA and ADRP protein, 8) while ADRP is degraded via the ubiquitin-proteasome mechanism when cellular triacylglycerol (TG) is reduced. 9, 10) These observations suggest that ADRP has a role in cellular fatty acid uptake and storage.
Placental transport of fatty acids to the fetus is essential for proper fetal growth and development. Fetal demand for fatty acids increases during the latter stages of pregnancy, and long chain n-3 polyunsaturated fatty acids (LCPUFA) are supplied from the maternal circulation.
11) Docosahexaenoic acid (DHA: 22 : 6, n-3) plays a particularly important role in fetal development because it is a major lipid constituent in the brain and retina. 12, 13) The blood DHA concentration is higher in the fetus than in maternal circulation, suggesting an active placental transfer. 12) In BeWo cells, a human placental choriocarcinoma cell line, DHA was preferentially incorporated into TG. 14) From postmortem studies of fetuses, stillbirths, and preterm infants, it was estimated that the fetus consumes Ͻ50-60 mg/d of n-3 LCPUFA during the last trimester of pregnancy, which are probably transferred from the placenta. 15) Peroxisome proliferator-activated receptor-g (PPARg) is a nuclear receptor that acts as a transcription factor by forming a heterodimer with its partner, retinoid X receptor (RXR). Both PPAR-g and RXR are essential for proper placental development, since disruption of these genes in mice resulted in embryonic death, with embryos exhibiting placental defects, including improper labyrinth development and reduced LD in trophoblasts. 16, 17) Sadovsky and colleagues demonstrated that PPARg enhances the differentiation of cultured primary term human trophoblasts, and that PPARg increases LDs in syncytiotrophoblasts. 18) Since it has been suggested that DHA is a natural ligand of RXR, 19, 20) we assumed that DHA plays a role in placental development through ADRP expression and LD formation.
In this study, we examined DHA-dependent ADRP expression in BeWo cells. BeWo cells, a human placental choriocarcinoma cell line, maintain several characteristics of natural trophoblasts. We showed that DHA induces Adrp mRNA expression and ADRP protein accumulation in BeWo cells. The DHA-dependent ADRP accumulation was inhibited by RXR-antagonists, indicating that DHA acts as a natural RXR-agonist to induce ADRP.
MATERIALS AND METHODS
Cell Culture BeWo cells were cultured in Ham's F12 medium with 15% fetal bovine serum (FBS) supplemented with 2 mM L-glutamine and 1% antibiotics (50 U/ml penicillin and 50 mg/ml streptomycin). The cells were maintained at 37°C in a 5% CO 2 atmosphere. Cells were supplemented with 100 mM DHA or oleic acid (OA) to induce LD formation. complexes with BSA as previously described. 9) To examine the effect of nuclear receptors, PA024 and HX630 (RXR agonist), 21, 22) PA452 and HX531 (RXR antagonist), 23, 24) GW1929 (PPARg agonist; Sigma), and GW9662 (PPARg antagonist; Alexis) were used. These reagents dissolved in dimethylsufoxide were added to the cells (10 ml DMSO/5 ml cell culture dish). As a control experiment, cells were treated with DMSO without the reagents under the same conditions. Real-Time Polymerase Chain Reaction (PCR) Total RNA from BeWo cells (1ϫ10 6 /dish) was extracted with ISO-GEN (Nippongene; Toyama, Japan) and reverse-transcribed with a Reverse Transcription Kit (Qiagen). Real time-PCR was performed using a SYBR Green I Master RT-PCR kit equipped with a LightCycler (Roche). The following primers were used: ADRP, 5Ј-AGTGGAAAAGGAGCATTGGA-3Ј and 5Ј-AGTTGAGGGGCGTGTTGTTA-3Ј; 18S, 5Ј-CGCC-GCTAGAGGTGAAATTCT-3Ј and 5Ј-CGAACCTCCGACT-TTCGTTCT-3Ј. The PCR conditions were 95°C for 10 min followed by 40 cycles of 10 s at 95°C, 10 s at 60°C, and 8 s at 72°C. The number of transcripts was quantified, and each sample was normalized on the basis of 18S content.
Immunoblot BeWo cells were homogenized in a buffer containing 1% Triton X-100, and the homogenate was centrifuged at 14000 rpm for 10 min at 4°C. Protein concentration was determined using the BCA protein assay reagent (Pierce; Rockford, IL, U.S.A.) with BSA as the standard. The cell lysates (20 mg protein) were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then electrotransferred onto a nitrocellulose membrane (Protran BA-83; Schleicher and Schuell). The membrane was blocked with TBS containing 3% BSA and then incubated for 1 h with antibody against ADRP (American Research Products 03-610102; Belmont, MA, U.S.A.), after which the positive bands were visualized with horseradish peroxidase (HRP)-conjugated anti-mouse immunoglobulin G (IgG) and an ECL Western blot detection kit (Perkin Elmer) and detected using X-ray film (RX-U; Fuji Film). The same membrane was reprobed with antibody against GAPDH (MAB374; Chemicon Inc.) or antibody against TIP47 (Santa Cruz Biotechnology). The intensities of bands were analysed using Scion Image analysis software.
Fluorescence Microscopy BeWo cells were cultured on chamber slides and were fixed with 2% formaldehyde in PBS for 20 min at room temperature and stained with Oil Red O to visualize neutral LD. After washing with PBS, the cells were incubated with anti-ADRP monoclonal antibody (dilution of 1 : 100 in PBS containing 0.1% BSA, and 0.1% saponin) followed by Alexa488-labeled goat anti-(mouse IgG) antibody (dilution 1 : 100), and nuclei were stained with DAPI.
Other Methods The amounts of TG were determined enzymatically using TG-test Wako (Wako Chemical Co., Osaka, Japan). Data are expressed as meansϮstandard deviation. Results were analyzed using Student's t-test, and statistical significance was assigned at pϽ0.05.
RESULTS
Effects of DHA on ADRP mRNA and Protein Expression Since DHA is a crucial nutrient for fetal development, we questioned whether DHA has an effect on lipid mobilization in placental cells. Incubation of BeWo cells with 100 mM DHA for up to 48 h increased the cellular amounts of ADRP protein and TG in a time-dependent manner (Figs. 1A, B) . Under the same conditions, Adrp mRNA expression was upregulated for about 5-fold by treatment with DHA for 24 h. The effect of DHA on induction of Adrp mRNA was more efficient than OA treatment (Fig. 1C) . DHA and OA increased intracellular ADRP protein and TG about 30-and 2-fold, respectively (Figs. 1D, E). The difference of mRNA level induced by these fatty acids was not directly correlated with the amount of ADRP protein, presumably because the Effect of DHA Was Blocked by RXR-Antagonists DHA is one of the natural RXR-agonistic fatty acids, while OA has little reactivity to RXR. 19, 20) To see whether the induction of ADRP by DHA in BeWo cells is medicated by RXR activation, we tested the effect of two RXR-antagonists, PA452 and HX531. Treatment of BeWo cells with 0.1 mM PA452 or HX531 together with 100 mM DHA significantly decreased the Adrp mRNA level (Fig. 2A) . These RXRantagonists completely blocked DHA-induced ADRP protein accumulation (Fig. 2B) . The induction of ADRP by OA, however, was not affected by the RXR-antagonists (Figs. 2B,  C) . These results show that DHA, but not OA, could increase Adrp transcripts through the activation of RXR. Interestingly, when BeWo cells were treated with both DHA and the RXR antagonists, TG accumulation was not affected in spite of a lack of ADRP protein (Fig. 2D) , and ADRP-poor LDs were observed in the cells (Fig. 2E) .
The amount of TIP47, another PAT family protein, was not changed by the addition of the fatty acids. Furthermore, the amount of TIP47 was not increased when ADRP was suppressed by the RXR antagonists (data not shown). These results suggest that TIP47 is not compensatory in BeWo cells under these conditions.
Effects of RXR Agonists on ADRP mRNA and Protein Expression To see the effects of RXR activation on ADRP protein expression, we added two specific RXR agonists, PA024 and HX630, to BeWo cells without DHA. Both agonists showed up-regulation of Adrp transcripts in BeWo cells (Fig. 3A) but did not increase ADRP protein levels (Fig. 3B) . Incubation of the cells with DHA alone induced ADRP protein concomitant with TG accumulation (Figs. 3B, C) . It has been reported that ADRP is degraded by a proteasomedependent pathway when the lipid source is limited in macrophages and hepatic cells. 9 ,10) Thus we tested the effect of a proteasome inhibitor, MG-132, on ADRP protein expression. The addition of MG-132 alone to the cells did not induce ADRP at all (data not shown); however, induction of ADRP protein by the RXR agonists was observed in the presence of MG-132 (Fig. 3D) , indicating that RXR activation is able to increase Adrp transcripts, but that ADRP protein is degraded by proteasomes without the addition of lipid sources.
Effects of PPARg g on ADRP mRNA and Protein Expression RXR can function as a heterodimer with the nuclear receptor superfamily. PPARg is an RXR heteropartner. We next investigated the effects of a PPARg-antagonist, GW9662, on ADRP expression. Treatment of BeWo cells with either 100 mM DHA or OA with 10 mM GW9662 significantly decreased the Adrp mRNA level and completely blocked ADRP protein accumulation (Figs. 4A, B) . However, GW9662 did not change the amount of TG accumulation in the presence of fatty acids in spite of decreased ADRP levels (Fig. 4C) .
We also examined the effect of a PPARg agonist, GW1929, on ADRP expression by DHA or OA. Treatment of BeWo cells with GW1929 alone slightly increased Adrp mRNA expression but did not increase ADRP protein levels (Figs. 4D, E) . Induction of Adrp mRNA and protein by DHA was enhanced by GW1929, but OA-induced Adrp mRNA and protein expression was not. However, no effect was observed on the amounts of TG by the agonist (Fig. 4F) . These results together with others indicate that the DHA increases ADRP levels through activation of RXR/PPARg heterodimer, and OA increased ADRP levels through PPARg activation independent of RXR.
DISCUSSION
Recent studies have shown that LD is a ubiquitously expressed orgalelle related to lipid homeostasis, and that ADRP and TIP47, two major PAT family proteins, are present in placenta.
1,2,5) DHA is not just an important nutrient for fetal development but is proposed to be a natural RXR agonist. 19, 20) Here we demonstrated that DHA, but not OA, functions as an RXR activator to induce ADRP expression in human choriocarcinoma cell line BeWo cells.
DHA-induced expression of ADRP protein in BeWo cells was significantly suppressed both by the RXR antagonists, PA452 and HX531, and by the PPARg antagonist, GW9662. Therefore it is likely that ADRP increases through transcriptional activation of the RXR/PPARg heterodimer. Some recent reports have suggested that ADRP gene transcription is up-regulated through PPAR-response elements by PPARs and RXR. induce ADRP protein expression in human placental trophoblasts. 6) Our current data correspond well with these observations, and further confirmed the RXR-dependent responses with experiments using RXR antagonists. In addition, we showed that DHA, but not OA, acts as a natural agonist of RXR. We note that the OA-induced response was not RXR-dependent but PPARg-dependent, since the antagonist for PPARg, but not RXR, blocked OA-induced ADRP expression. de Urquiza et al. showed that DHA and arachidonic acid but not OA activate RXR in in vitro reporter gene assay. 19) On the other hand, Auwerx reported that DHA bind and activate PPARg. 27) It is likely that the DHA increases ADRP expression through both activation of RXR-homodimer and RXR/PPARg heterodimer in BeWo cells.
DHA is required for fetus development during pregnancy. The proportion of DHA in fetal plasma was shown to be higher than maternal plasma, and DHA concentration in the plasma from maternal vein blood was 41.9Ϯ20.9 mg/ml. 15) Since the molecular weight of the DHA is 328.5, 100 mM of DHA used in this study is equal to 32.9 mg/ml. Thus, our experimental condition could reflect the maternal circulation. It has been speculated that DHA-dependent induction of ADRP is of physiological importance. DHA is most effectively taken up by fetal cells, whereas human hepatoma cell lines HepG2 and HuH-7 show no preference for fatty acid species. 28, 29) DHA-dependent induction of ADRP was far more sensitive to the RXR antagonists in BeWo cells than in HuH-7 cells, which required about 10 mM (data not shown). Certainly more studies are needed to elucidate the physiological relevance of DHA-dependent RXR activation during pregnancy, but our study opens up the possibility that regulation of lipid metabolism in placental development could be a useful target.
In this study, DHA increases cellular TG level in BeWo cells and it is previously reported that DHA raises TG accumulation in other cells, such as hepatocyte. 30) However, in 3T3-L1 preadipocytes, DHA suppressed cellular lipid accumulation during adipocyte differentiation, 31) suggesting that the effect of the DHA is different by cell types.
In our experiments, we observed ADRP-poor LD formation by suppression of ADRP by RXR antagonists. It is thought that LD should be covered and stabilized by some proteins such as PAT family proteins. Chan et al. reported that LD formed in the liver of ADRP-null mice is enriched with another LD-coating protein, TIP47.
32) It is interesting that TIP47 was not up-regulated when the ADRP-poor LD was formed in BeWo cells by the RXR antagonists. There might be some other LD-coating proteins on the ADRP-poor LD particles.
We note that induction of Adrp mRNA does not directly correlate to ADRP protein levels. The fatty acids itself are not only substrates for TG biosynthesis but also the regulation as the transcription factor activity. Our results suggest that the bifunctional of the fatty acids are necessary for ADRP stabilization. We and others have shown that ADRP protein can be degraded by a proteasome-dependent pathway in macrophages and hepatic cells when cellular amount of TG is poor. 9, 10) Our data suggest that similar post-translational regulation could occur in BeWo cells, since results with the proteasome inhibitor MG-132 suggest that ADRP protein synthesis should have been enhanced by addition of the RXR agonists.
In conclusion, DHA acts as a natural ligand of RXR and increases ADRP expression in BeWo cells. The amount of ADRP in the cells depends not only on the transcriptional level, but also on the availability of lipids.
